CAQ Corner: Psychosocial and ethical considerations in patient selection for liver transplantation
Gerald Scott Winder, Jessica L. Mellinger – 3 April 2022
CAQ Corner: Genetic liver disease
James E. Squires, Simon P. Horslen – 3 April 2022
CAQ Corner: Genetic liver disease
James E. Squires, Simon P. Horslen – 3 April 2022
Heterogeneity of hepatic steatosis definitions and reporting of donor liver frozen sections among pathologists: A multicenter survey
Sam Ho, Enoch Kuo, Daniela Allende, Hanlin L. Wang, Maria Westerhoff, Rondell P. Graham, Romil Saxena, Raul S. Gonzalez, Maria Isabel Fiel, Zhaohai Yang, Xuchen Zhang, Xiuli Liu – 3 April 2022
CAQ Corner: Psychosocial and ethical considerations in patient selection for liver transplantation
Gerald Scott Winder, Jessica L. Mellinger – 3 April 2022
Alloantibody and crossmatch in simultaneous liver and kidney transplantation: Is the jury still out?
Brittany Rocque, Sean Martin, Juliet Emamaullee, Yong Kwon – 2 April 2022
Innate lymphoid cells at the crossroads of innate and adaptive immunity
Firouzeh Korangy, Bernd Heinrich, Tim F. Greten – 1 April 2022
Letter to the editor: Effect of diabetes medications and glycemic control on risk of HCC in patients with NAFLD
Yibing Zhou, Weike Chu, Xue Wu, Hui Zhou, Bin Niu, Ze Chen, Yuqiang Mi, Ping Li – 1 April 2022
HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection
Michel Bazinet, Mark Anderson, Victor Pântea, Gheorghe Placinta, Iurie Moscalu, Valentin Cebotarescu, Lilia Cojuhari, Pavlina Jimbei, Liviu Iarovoi, Valentina Smesnoi, Tatina Musteata, Alina Jucov, Ulf Dittmer, Jeff Gersch, Vera Holzmayer, Mary Kuhns, Gavin Cloherty, Andrew Vaillant – 1 April 2022 – Nucleic acid polymers block the assembly of hepatitis B virus (HBV) subviral particles, effectively preventing hepatitis B surface antigen (HBsAg) replenishment in the circulation.
Intestinal virome in patients with alcohol use disorder and after abstinence
Cynthia L. Hsu, Xinlian Zhang, Lu Jiang, Sonja Lang, Phillipp Hartmann, David Pride, Derrick E. Fouts, Peter Stärkel, Bernd Schnabl – 1 April 2022 – Alcohol use is a leading cause of chronic liver disease worldwide, and changes in the microbiome associated with alcohol use contribute to patients’ risk for liver disease progression. Less is known about the effects of alcohol use on the intestinal viral microbiome (virome) and interactions between bacteriophages and their target bacteria.